WuXi Biologics (Cayman) Inc.
(Incorporated in the Cayman Islands with limited liability)

Press Releases       

2022-March-22	WuXi Biologics Achieved Record Growth and Profitability in 2021, Banner Year for Commercial Manufacturing, Revenue Increased by 83.3% Y-o-Y to RMB10,290.1 Million, Gross Profit Increased by 90.6% Y-o-Y to RMB4,828.9 Million, Net Profit Grew by 107.3% Y-o-Y to RMB3,508.6 Million, Adjusted Net Profit Rose by 100.3% to RMB3,435.9 Million, Total Backlog Grew 20.1% to US$13,597 Million (in PDF)
2021	2021 Press Releases
2020	2020 Press Releases
2019	2019 Press Releases
2018	2018 Press Releases
2017	2017 Press Releases